TEVA Teva Pharmaceutical Industries Ltd

  • STOCK
  • TEVA
  • Price as of: Dec 19, 10:24 PM EST
  • $58.00
  • +$1.35
  • +2.4%
  • Industry
  • Drug manufacturers - other
Share

TEVA Stock Dividend Data

Add TEVA to Watchlist
  • Dividend Yield
    1.88% Healthcare Average 2.29%
  • Annual Payout
    $1.09 Paid Quarterly
  • Payout Ratio
    21.5% EPS $5.06
  • Dividend Growth
    1 yr Since 2013
  • Get TEVA DARS™ Rating
DARS Rating™ Breakdown

Dividend.com DARS Rating™ Breakdown for TEVA

Sign Up
Metric TEVA Rank TEVA Avg Ranking Notes
Relative Strength Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock is slightly underperforming.
Overall Yield Attractiveness Sign Up For Ticker Ranking Sign Up For Sector Ranking Stock's dividend yield is above average.
Dividend Reliability Sign Up For Ticker Ranking Sign Up For Sector Ranking This rating is related to the length and consistency of a company's dividend payouts, as well as our opinion on how likely the company is to continue payouts in the future.
Dividend Uptrend Sign Up For Ticker Ranking Sign Up For Sector Ranking Dividend payouts are consistent, but increases small.
Earnings Growth Sign Up For Ticker Ranking Sign Up For Sector Ranking Earnings estimates have been cut slightly.
DARS Rating Sign Up For Ticker Ranking Sign Up For Sector Ranking Sign Up For DARS Ratings
Growth History

TEVA Dividend Growth History

Annualized Growth
1994-2012
Annualized Growth
1994-2004
Annualized Growth
2004-2008
Annualized Growth
2008-2012
Annualized Growth
Last 5 Yrs
Annualized Growth
Last 3 Yrs
Annual
Growth
2012
Consecutive
Years of
Increases
Reveal More Dividend Growth History for TEVA 17.6% 35.1% 1 year
Reveal More Dividend Growth History for TEVA
Historical Annual Dividend Data & Growth

TEVA Historical Annual Dividend Data & Growth

Payout Amount Calendar Year Annual Growth
$1.0863 2013 35.1%
$0.8039 2012 -18.3%
Historical Dividend Data

TEVA Dividend History

Payout Amount Declared Date Ex-Dividend Date Record Date Pay Date ▼ Qualified Dividend? Payout Type Frequency
$0.2696 2014-11-13 2014-11-17 2014-12-02 Unknown Regular Quarter
$0.2911 2014-08-19 2014-08-21 2014-09-04 Unknown Regular Quarter
$0.2978 2014-05-16 2014-05-20 2014-06-02 Unknown Regular Quarter
$0.2930 2014-02-20 2014-02-24 2014-03-10 Unknown Regular Quarter
$0.2775 2013-11-18 2013-11-20 2013-12-03 Unknown Regular Quarter
$0.2737 2013-08-16 2013-08-20 2013-09-03 Unknown Regular Quarter
$0.2682 2013-05-16 2013-05-20 2013-06-03 Unknown Regular Quarter
$0.2669 2013-02-19 2013-02-21 2013-03-07 Unknown Regular Quarter
$0.2024 2012-11-13 2012-11-15 2012-12-03 Unknown Regular Quarter
$0.2083 2012-08-13 2012-08-15 2012-09-04 Unknown Regular Quarter
$0.1960 2012-05-17 2012-05-21 2012-06-04 Unknown Regular Quarter
$0.1972 2012-02-23 2012-02-27 2012-03-13 Unknown Regular Quarter
$0.1719 2011-11-09 2011-11-14 2011-12-07 Unknown Regular Quarter
$0.1963 2011-08-04 2011-08-03 2011-08-25 Unknown Regular Quarter
$0.1996 2011-08-04 2011-08-03 2011-08-25 Unknown Regular Quarter
$0.1999 2011-05-19 2011-05-23 2011-06-07 Unknown Regular Quarter
$0.2168 2011-02-10 2011-02-14 2011-03-07 Unknown Regular Quarter
$0.1730 2010-11-08 2010-11-10 2010-12-06 Unknown Regular Quarter
$0.1670 2010-08-02 2010-08-04 2010-08-26 Unknown Regular Quarter
$0.1632 2010-05-10 2010-05-12 2010-06-04 Unknown Regular Quarter
$0.1640 2010-02-19 2010-02-23 2010-03-17 Unknown Regular Quarter
$0.1254 2009-11-06 2009-11-10 2009-12-04 Unknown Regular Quarter
$0.1248 2009-08-03 2009-08-05 2009-08-27 Unknown Regular Quarter
$0.1203 2009-05-08 2009-05-12 2009-06-03 Unknown Regular Quarter
$0.1120 2009-02-23 2009-02-25 2009-03-19 Unknown Regular Quarter
$0.0931 2008-11-07 2008-11-12 2008-12-05 Unknown Regular Quarter
$0.1042 2008-08-01 2008-08-05 2008-08-27 Unknown Regular Quarter
$0.1126 2008-05-13 2008-05-15 2008-06-05 Unknown Regular Quarter
$0.1017 2008-02-15 2008-02-20 2008-03-13 Unknown Regular Quarter
$0.0840 2007-11-02 2007-11-06 2007-11-28 Unknown Regular Quarter
$0.0802 2007-08-10 2007-08-14 2007-09-06 Unknown Regular Quarter
$0.0833 2007-05-10 2007-05-14 2007-06-05 Unknown Regular Quarter
$0.0787 2007-02-16 2007-02-21 2007-03-15 Unknown Regular Quarter
$0.0657 2006-11-10 2006-11-14 2006-12-06 Unknown Regular Quarter
$0.0643 2006-08-11 2006-08-15 2006-09-08 Unknown Regular Quarter
$0.0626 2006-05-12 2006-05-16 2006-06-07 Unknown Regular Quarter
$0.0607 2006-03-06 2006-03-08 2006-03-30 Unknown Regular Quarter
$0.0519 2005-11-10 2005-11-15 2005-12-07 Unknown Regular Quarter
$0.0543 2005-08-11 2005-08-15 2005-09-07 Unknown Regular Quarter
$0.0559 2005-05-05 2005-05-09 2005-06-01 Unknown Unknown unknown
$0.0559 2005-02-17 2005-02-22 2005-03-17 Unknown Unknown unknown
$0.0414 2004-11-09 2004-11-12 2004-12-06 Unknown Unknown unknown
$0.0401 2004-08-09 2004-08-11 2004-09-07 Unknown Unknown unknown
2-for-1 2004-07-01 2004-06-24 2004-06-30 NM Stock Split NM
$0.0384 2004-05-10 2004-05-12 2004-06-07 Unknown Unknown unknown
$0.0391 2004-02-20 2004-02-25 2004-03-22 Unknown Unknown unknown
$0.0294 2003-11-13 2003-11-17 2003-12-12 Yes Unknown unknown
$0.0298 2003-08-08 2003-08-12 2003-09-08 Yes Unknown unknown
$0.0291 2003-05-08 2003-05-12 2003-06-06 Yes Unknown unknown
$0.0273 2003-02-24 2003-02-26 2003-03-24 Yes Unknown unknown
$0.0369 2002-11-07 2002-11-12 2002-12-06 Unknown Unknown unknown
$0.0369 2002-08-19 2002-08-21 2002-09-16 Unknown Unknown unknown
$0.0351 2002-05-20 2002-05-22 2002-06-17 Unknown Unknown unknown
$0.0386 2002-02-15 2002-02-20 2002-03-18 Unknown Unknown unknown
$0.0266 2001-11-16 2001-11-20 2001-12-17 Unknown Unknown unknown
$0.0249 2001-08-20 2001-08-21 2001-09-17 Unknown Unknown unknown
$0.0243 2001-05-17 2001-05-21 2001-06-15 Unknown Unknown unknown
$0.0239 2001-03-08 2001-03-12 2001-04-06 Unknown Unknown unknown
$0.0204 2000-11-16 2000-11-20 2000-12-15 Unknown Unknown unknown
$0.0208 2000-08-24 2000-08-28 2000-09-21 Unknown Unknown unknown
$0.0203 2000-05-19 2000-05-23 2000-06-19 Unknown Unknown unknown
$0.0210 2000-02-17 2000-02-22 2000-03-27 Unknown Unknown unknown
2-for-1 2000-02-23 2000-02-22 2000-03-02 NM Stock Split NM
$0.0132 1999-11-04 1999-11-08 1999-11-30 Unknown Unknown unknown
$0.0132 1999-08-18 1999-08-20 1999-09-13 Unknown Unknown unknown
$0.0135 1999-05-21 1999-05-25 1999-06-15 Unknown Unknown unknown
$0.0138 1999-03-08 1999-03-10 1999-03-30 Unknown Unknown unknown
$0.0133 1998-11-20 1998-11-24 1998-12-11 Unknown Unknown unknown
$0.0145 1998-08-21 1998-08-25 1998-09-11 Unknown Unknown unknown
$0.0160 1998-05-21 1998-05-26 1998-06-22 Unknown Unknown unknown
$0.0162 1998-03-12 1998-03-16 1998-03-31 Unknown Unknown unknown
$0.0167 1997-11-20 1997-11-24 1997-12-09 Unknown Unknown unknown
$0.0167 1997-08-25 1997-08-27 1997-09-11 Unknown Unknown unknown
$0.0173 1997-05-23 1997-05-28 1997-06-12 Unknown Unknown unknown
$0.0174 1997-03-07 1997-03-11 1997-03-26 Unknown Unknown unknown
$0.0117 1996-11-20 1996-11-22 1996-12-09 Unknown Unknown unknown
$0.0123 1996-08-26 1996-08-28 1996-09-12 Unknown Unknown unknown
$0.0119 1996-05-23 1996-05-28 1996-06-12 Unknown Unknown unknown
$0.0126 1996-03-07 1996-03-11 1996-03-26 Unknown Unknown unknown
$0.0121 1995-11-20 1995-11-22 1995-12-07 Unknown Unknown unknown
$0.0122 1995-08-14 1995-08-16 1995-08-30 Unknown Unknown unknown
$0.0128 1995-05-17 1995-05-23 1995-06-07 Unknown Unknown unknown
$0.0128 1995-03-07 1995-03-13 1995-04-04 Unknown Unknown unknown
$0.0127 1994-11-15 1994-11-21 1994-12-13 Unknown Unknown unknown
$0.0129 1994-08-09 1994-08-15 1994-09-12 Unknown Unknown unknown
$0.0128 1994-05-18 1994-05-24 1994-06-21 Unknown Unknown unknown
$0.0131 1994-03-08 1994-03-14 1994-04-05 Unknown Unknown unknown
$0.0100 1993-11-17 1993-11-22 1994-01-03 Unknown Unknown unknown
$0.0110 1993-08-17 1993-08-23 1993-09-14 Unknown Unknown unknown
$0.0076 1993-05-18 1993-05-24 1993-06-21 Unknown Unknown unknown
$0.0077 1993-04-07 1993-04-14 1993-05-05 Unknown Unknown unknown
5-for-3 1993-04-14 1993-04-08 1993-04-13 NM Stock Split NM
Company Profile

TEVA Company Profile

Exchange: NYSE
Sector: Healthcare

Teva Pharmaceutical Industries Ltd (TEVA) is an Israeli global pharmaceutical company. It develops, produces and markets generic drugs in all treatment categories. Its principal branded pharmaceutical products include Copaxone, Provigil, Nuvigil, Azilect, and Plan B One-Step. Teva is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The firm is based out of Petah Tikva, Israel and was founded in 1901.

High Yield Stocks

High Yield Stocks

Looking for dividend stocks with great yields? Visit our list of:

High Yield Dividend Stocks
News

Teva Pharmaceutical Industries Ltd News

  • Teva Pharmaceutical to Cut 5,000 Jobs (TEVA)

    Teva Pharmaceutical Industries Ltd (TEVA) announced on Thursday that it plans to cut 5,000 jobs in an effort to reduce costs. The pharmaceutical company stated that cutting 5,000 jobs, which accounts for 10% of its workforce, will save the company an estimated $2 billion a year. These cuts are a part of the company's cost-cutting goals, which it hopes to achieve by the end of 2017. Teva estimates that roughly $1 billion will be saved by the end of 2014, and the remaining 70% would come by the end of 2015. This comes after CEO Jeremy Levin vowed in December that the company would reduce annual costs by $1.5 billion to $2 billion over five years. Teva Pharmaceutical shares rallied 3.38% during Thursday's session. Year-to-date, the stock is up 5.40%.

    The Bottom Line

    Shares of Teva Pharmaceutical Industries Ltd (TEVA) currently yield 2.69% based on Thursday's closing price of $40.57 and its annual payout of $1.09. Teva Pharmaceutical Industries Ltd (TEVA)  is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • Teva Acquires MicroDose Therapeutx (TEVA)

    Today, Teva Pharmaceuticals (TEVA) announced the purchase of MicroDose Therapeutx for $40M. The Israel-based firm made the move in order to expand its line-up of respiratory products. MicroDose, a private firm, focuses on inhalation technologies to treat lung ailments. Investors should note that as a part of the deal, Teva may pay up to $125 million if certain developmental targets are met. Teva is currently the largest generic drug manufacturer in the world and trades on both the NYSE and the Tel Aviv Stock Exchange. Teva shares were up $0.24 or 0.61% at Monday's close. The stock is currently 8% off of its 52-week highs. The Bottom Line Shares of Teva Pharmaceuticals (TEVA) have a yield of 2.77% based on Monday's closing price of $39.32. Teva Pharmaceuticals (TEVA) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Lennar Corp...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Teva...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Teva...
  • Teva Pharmaceutical's Numbers Cut at Needham & Co. (TEVA)

    Israeli drug maker Teva Pharmaceutical Industries Ltd (TEVA) on Friday caught some tepid commentary from analysts at Needham & Company. The firm maintained its "Hold" rating on TEVA but lowered its 2012 EPS estimate from $5.59 to $5.34, and its 2013 EPS estimate from $6.01 to $5.70. A Needham analyst commented, "A quick two weeks post effectively withdrawing 2012 financial guidance, new Teva management emerged with updated near-term financial objectives that while differing only marginally from prior guidance in the aggregate, clearly set a floor under the 'how bad can it be' thinking that has hung over shares post 1Q12 results. Given current state of sentiment in the name with shares plunging the depths of oversold territory reached on only four occasions in the past decade, a reflex rally is overdue though key structural overhangs, longer-term opacity on evolution of growth initiatives and revamping of strategic priorities, we find little compelling reason to support a significant fundamental outperformance thesis." Teva shares were unchanged in premarket trading Friday. The Bottom Line Shares of Teva Pharmaceuticals (TEVA) have a 2.77% dividend yield, based on last night's closing stock price of $38.69. The stock has technical support in the $35-$36 price area. If the shares can firm up, we see overhead resistance around the $42 price level. Teva Pharmaceutical Industries Ltd (TEVA) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.2 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights International...
  • Teva Pharmaceuticals to Buy Cephalon for $6.8 Billion in Cash (TEVA)

    Israeli drugmaker Teva Pharmaceutical Industries Ltd (TEVA) on Monday announced it would acquire rival pharma company Cephalon (CEPH) for $6.8 billion in cash. The agreed-upon deal marks the end of Valeant Pharmaceuticals' (VRX) hostile bid for Cephalon. Valeant had bid $73, which Cephalon's board rejected as undervaluing the company. Teva will pay $81.50 for CEPH, which marks a 6% upside from the stock's Friday closing price of $77.02. The deal is expected to close in the third quarter. Teva Pharmaceuticals shares rose $1.57, or +3.4%, in premarket trading Monday. The Bottom Line Shares of Teva Pharmaceuticals (TEVA) have a 1.88% dividend yield, based on Friday's closing stock price of $45.73. The stock has technical support in the $40-$42 price area. If the shares can firm up, we see overhead resistance around the $48-$50 price levels. Teva Pharmaceutical Industries Ltd (TEVA) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.
    Expand to read the full story
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Diamond Foods...
  • These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Enterprise GP...